CHKA and colorectal carcinoma: Together with the finding that the CHKA/TNM stage combination had a more powerful efficiency for predicting the outcome of patients than either parameter alone, our current results suggest that combination of CHKA with TNM stage may serve as a promising prognostic biomarker to stratify CRC patients into distinct risk subgroups and guide individualized therapy.